|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500106230 |
|
最近更新日期: Date of Last Refreshed on: |
2025-07-21 10:21:33 |
|
注册时间: Date of Registration: |
2025-07-21 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
急性脑血管病与季节关系的回顾性研究 |
|
Public title: |
A retrospective study of the relationship between acute cerebrovascular disease and season |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
急性脑血管病与季节关系的回顾性研究 |
|
Scientific title: |
A retrospective study of the relationship between acute cerebrovascular disease and season |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘羽 |
研究负责人: |
刘羽 |
|
Applicant: |
Yu Liu |
Study leader: |
Yu Liu |
|
申请注册联系人电话: Applicant telephone: |
+86 15088105680 |
研究负责人电话:
Study leader's |
+86 756 2222569 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
liuyuly1982@163.com |
研究负责人电子邮件: Study leader's E-mail: |
liuyuly1982@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广东省珠海市香洲区康宁路79号 |
研究负责人通讯地址: |
广东省珠海市香洲区康宁路79号 |
|
Applicant address: |
No. 79, Kangning Road, Xiangzhou District, Zhuhai City, Guangdong Province |
Study leader's address: |
No. 79, Kangning Road, Xiangzhou District, Zhuhai City, Guangdong Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
珠海市人民医院 |
||
|
Applicant's institution: |
Zhuhai People's Hospital |
||
|
研究负责人所在单位: |
珠海市人民医院 |
||
|
Affiliation of the Leader: |
Zhuhai People's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(2025)伦审【研】第(2)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
珠海市人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Zhuhai People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-01-03 00:00:00 | ||
|
伦理委员会联系人: |
温宇云 |
||
|
Contact Name of the ethic committee: |
Wen Yuyun |
||
|
伦理委员会联系地址: |
广东省珠海市香洲区康宁路79号 |
||
|
Contact Address of the ethic committee: |
No. 79, Kangning Road, Xiangzhou District, Zhuhai City, Guangdong Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 756 2158211 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
963179547@qq.com |
|
研究实施负责(组长)单位: |
珠海市人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Zhuhai People's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广东省珠海市香洲区康宁路79号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 79, Kangning Road, Xiangzhou District, Zhuhai City, Guangdong Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自选课题(自筹) |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-selected project (self-funded) |
||||||||||||||||||||||
|
研究疾病: |
缺血性脑卒中 |
||||||||||||||||||||||
|
Target disease: |
Ischemic stroke |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
主要研究目的:探讨急性脑血管病发病的季节性分布规律;研究各气象因素与急性脑血管病发病的相关性 次要研究目的:探讨季节对急性脑血管病患者预后的影响 |
||||||||||||||||||||||
|
Objectives of Study: |
The main research objective: To explore the seasonal distribution pattern of acute cerebrovascular disease onset; to study the correlation between various meteorological factors and the onset of acute cerebrovascular disease. The secondary research objective: To investigate the impact of seasons on the prognosis of patients with acute cerebrovascular disease. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.性别不限,年龄≥18岁; |
||||||||||||||||||||||
|
Inclusion criteria |
1.Gender is not limited, age >= 18 years; 2.Meet the standards of the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023" and "Chinese Guidelines for the Diagnosis and Treatment of Intracerebral Hemorrhage 2019"; 3.The medical record is complete, including the date of onset, clinical features, and imaging findings. |
||||||||||||||||||||||
|
排除标准: |
1.患有以下疾病:短暂性脑缺血发作(TIA)、外伤性脑出血、脑肿瘤导致的继发性出血、脑血管畸形、合并其他严重中枢神经系统疾病(如脑肿瘤、脑外伤)伴有严重的系统性疾病影响研究结果者; |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Those with the following diseases: transient ischemic attack (TIA), traumatic intracerebral hemorrhage, secondary hemorrhage caused by brain tumor, cerebrovascular malformation, combined with other serious central nervous system diseases (such as brain tumors, brain trauma) with severe systemic diseases that affect the results of the study; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-08-01 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-08-01 00:00:00 至 To 2025-08-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
no |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2025年12月,可以与课题负责人取得联系,并通过书面申请索取,获得原始数据。(liuyuly1982@163.com) |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
In December 2025, the project leader can be contacted and the original data can be obtained through a written application. (liuyuly1982@163.com) |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
从医院HIS电子病历系统中提取患者信息,使用统一的资料收集表,确保数据的完整性和一致性。 1.数据采集 建立电子数据库,采用双人独立录入,提高准确性; 数据加密存储,设置访问权限,保护患者隐私; 定期进行数据备份,防止数据丢失。 2.数据管理计划与质量控制 本研究采用规范化的数据管理与质量控制方案:制定数据采集、录入和质控标准操作规程(SOP),对所有研究人员进行岗前培训和定期培训;采用双人双份独立录入方式,通过系统自动比对发现差异;执行每日数据完整性检查和逻辑核查,对发现的问题及时反馈纠正;定期进行质量分析和评估,确保数据完整性≥98%、准确性≥95%;同时建立数据备份和人员更替应急预案,保证研究持续进行。所有数据修改均需申请、审批和记录,确保数据可追溯。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Extract patient information from the hospital's HIS electronic medical record system and use a unified data collection form to ensure data integrity and consistency. 1. Data collection Establish an electronic database and use two-person independent input to improve accuracy; Data is encrypted and stored, and access rights are set to protect patient privacy; Make regular data backups to prevent data loss. 2. Data management plan and quality control This study adopts a standardized data management and quality control scheme: the standard operating procedures (SOPs) for data collection, entry and quality control are formulated, and pre-job training and regular training are provided to all researchers; The method of independent entry of two people and two copies is adopted, and the difference is found through automatic comparison of the system; Perform daily data integrity checks and logic checks, and provide timely feedback and correction of problems found; Conduct regular quality analysis and evaluation to ensure that data integrity >= 98% and accuracy >= 95%; At the same time, an emergency plan for data backup and personnel replacement is established to ensure the continuous progress of the research. All data modifications are requested, approved, and documented to ensure data traceability. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |